vs
enCore Energy Corp.（EU）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是enCore Energy Corp.的1.6倍（$19.6M vs $12.4M），enCore Energy Corp.净利率更高（-173.9% vs -177.4%，领先3.5%），enCore Energy Corp.自由现金流更多（$7.2M vs $-23.1M）
德文能源是一家美国 hydrocarbon 勘探企业，公司注册于特拉华州，运营总部位于俄克拉荷马州俄克拉荷马城的德文能源中心，业务区块主要集中在特拉华盆地、伊格尔福特区块以及落基山脉区域，是美国本土重要的能源勘探开发企业。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
EU vs LAB — 直观对比
营收规模更大
LAB
是对方的1.6倍
$12.4M
净利率更高
EU
高出3.5%
-177.4%
自由现金流更多
EU
多$30.2M
$-23.1M
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $12.4M | $19.6M |
| 净利润 | $-21.5M | $-34.7M |
| 毛利率 | 37.9% | 48.5% |
| 营业利润率 | -135.9% | -168.5% |
| 净利率 | -173.9% | -177.4% |
| 营收同比 | — | -11.5% |
| 净利润同比 | — | -28.8% |
| 每股收益（稀释后） | $-0.11 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EULAB
| Q4 25 | $12.4M | — | ||
| Q3 25 | $8.9M | $19.6M | ||
| Q2 25 | $3.7M | $21.8M | ||
| Q1 25 | $18.2M | $40.8M | ||
| Q3 24 | — | $22.1M | ||
| Q2 24 | — | $22.5M | ||
| Q1 24 | — | $45.5M | ||
| Q4 23 | — | $28.2M |
净利润EULAB
| Q4 25 | $-21.5M | — | ||
| Q3 25 | $-4.8M | $-34.7M | ||
| Q2 25 | $-6.3M | $-33.5M | ||
| Q1 25 | $-24.2M | $-26.0M | ||
| Q3 24 | — | $-26.9M | ||
| Q2 24 | — | $-45.7M | ||
| Q1 24 | — | $-32.2M | ||
| Q4 23 | — | $-19.8M |
毛利率EULAB
| Q4 25 | 37.9% | — | ||
| Q3 25 | 43.8% | 48.5% | ||
| Q2 25 | 30.8% | 48.8% | ||
| Q1 25 | -0.1% | 48.4% | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | — | 53.1% | ||
| Q4 23 | — | 47.6% |
营业利润率EULAB
| Q4 25 | -135.9% | — | ||
| Q3 25 | -158.2% | -168.5% | ||
| Q2 25 | -526.1% | -118.1% | ||
| Q1 25 | -85.7% | -80.8% | ||
| Q3 24 | — | -120.9% | ||
| Q2 24 | — | -134.5% | ||
| Q1 24 | — | -132.2% | ||
| Q4 23 | — | -75.9% |
净利率EULAB
| Q4 25 | -173.9% | — | ||
| Q3 25 | -53.7% | -177.4% | ||
| Q2 25 | -172.7% | -153.7% | ||
| Q1 25 | -132.9% | -63.8% | ||
| Q3 24 | — | -122.0% | ||
| Q2 24 | — | -203.3% | ||
| Q1 24 | — | -70.6% | ||
| Q4 23 | — | -70.2% |
每股收益（稀释后）EULAB
| Q4 25 | $-0.11 | — | ||
| Q3 25 | $-0.03 | $-0.09 | ||
| Q2 25 | $-0.03 | $-0.09 | ||
| Q1 25 | $-0.13 | $-0.07 | ||
| Q3 24 | — | $-0.07 | ||
| Q2 24 | — | $-0.12 | ||
| Q1 24 | — | $-0.27 | ||
| Q4 23 | — | $-0.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $52.4M | $129.4M |
| 总债务越低越好 | $110.0M | — |
| 股东权益账面价值 | $229.2M | $399.7M |
| 总资产 | $430.4M | $539.6M |
| 负债/权益比越低杠杆越低 | 0.48× | — |
8季度趋势，按日历期对齐
现金及短期投资EULAB
| Q4 25 | $52.4M | — | ||
| Q3 25 | $91.9M | $129.4M | ||
| Q2 25 | $26.9M | $158.6M | ||
| Q1 25 | $29.7M | $150.9M | ||
| Q3 24 | — | $210.6M | ||
| Q2 24 | — | $269.8M | ||
| Q1 24 | — | $287.1M | ||
| Q4 23 | — | $51.7M |
总债务EULAB
| Q4 25 | $110.0M | — | ||
| Q3 25 | $109.3M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M | ||
| Q4 23 | — | $63.5M |
股东权益EULAB
| Q4 25 | $229.2M | — | ||
| Q3 25 | $248.6M | $399.7M | ||
| Q2 25 | $264.7M | $424.5M | ||
| Q1 25 | $267.9M | $454.6M | ||
| Q3 24 | — | $489.3M | ||
| Q2 24 | — | $510.3M | ||
| Q1 24 | — | $577.3M | ||
| Q4 23 | — | $-148.1M |
总资产EULAB
| Q4 25 | $430.4M | — | ||
| Q3 25 | $441.9M | $539.6M | ||
| Q2 25 | $359.4M | $557.0M | ||
| Q1 25 | $362.6M | $579.6M | ||
| Q3 24 | — | $681.5M | ||
| Q2 24 | — | $708.7M | ||
| Q1 24 | — | $777.7M | ||
| Q4 23 | — | $323.1M |
负债/权益比EULAB
| Q4 25 | 0.48× | — | ||
| Q3 25 | 0.44× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× | ||
| Q4 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.9M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $7.2M | $-23.1M |
| 自由现金流率自由现金流/营收 | 57.8% | -118.1% |
| 资本支出强度资本支出/营收 | 46.7% | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-45.0M | $-111.1M |
8季度趋势，按日历期对齐
经营现金流EULAB
| Q4 25 | $12.9M | — | ||
| Q3 25 | $-20.3M | $-22.2M | ||
| Q2 25 | $-9.9M | $-20.7M | ||
| Q1 25 | $-7.7M | $-30.3M | ||
| Q3 24 | — | $-27.9M | ||
| Q2 24 | — | $-39.0M | ||
| Q1 24 | — | $-62.5M | ||
| Q4 23 | — | $-14.1M |
自由现金流EULAB
| Q4 25 | $7.2M | — | ||
| Q3 25 | $-26.3M | $-23.1M | ||
| Q2 25 | $-14.1M | $-22.6M | ||
| Q1 25 | $-11.7M | $-35.3M | ||
| Q3 24 | — | $-30.1M | ||
| Q2 24 | — | $-41.0M | ||
| Q1 24 | — | $-63.3M | ||
| Q4 23 | — | $-14.1M |
自由现金流率EULAB
| Q4 25 | 57.8% | — | ||
| Q3 25 | -296.6% | -118.1% | ||
| Q2 25 | -385.2% | -103.6% | ||
| Q1 25 | -64.1% | -86.6% | ||
| Q3 24 | — | -136.4% | ||
| Q2 24 | — | -182.2% | ||
| Q1 24 | — | -138.9% | ||
| Q4 23 | — | -50.2% |
资本支出强度EULAB
| Q4 25 | 46.7% | — | ||
| Q3 25 | 68.0% | 4.5% | ||
| Q2 25 | 115.1% | 8.7% | ||
| Q1 25 | 21.7% | 12.4% | ||
| Q3 24 | — | 10.2% | ||
| Q2 24 | — | 8.6% | ||
| Q1 24 | — | 1.7% | ||
| Q4 23 | — | 0.3% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EU
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
